Three-dimensional printing of drug-eluting implants: Preparation of an antimicrobial polylactide feedstock material

Journal of Pharmaceutical Sciences

Volumn 104, Issue 3, 2015, Pages 1099-1107

  Water, Jorrit Jeroen ^a   Bohr, Adam ^a   Boetker, Johan ^a   Aho, Johanna ^a   Sandler, Niklas ^b   Nielsen, Hanne Mørck ^a   Rantanen, Jukka ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b ÅBO AKADEMI UNIVERSITY   (Finland)

Author keywords

Antiinfectives; Biomaterials; Controlled release; Drug delivery systems; Extrusion; Microscopy; Poly(lactic glycolic) acid (PLGA or PLA); Polymeric drug delivery systems; Polymers; Spectroscopy

Indexed keywords

BIOMATERIAL; HYDROXYAPATITE; NITROFURANTOIN; POLYLACTIDE; ANTIINFECTIVE AGENT; DELAYED RELEASE FORMULATION; DRUG CARRIER; NANOPARTICLE; POLYESTER;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BIOFILM; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG RELEASE; GROWTH INHIBITION; NONHUMAN; PHYSICAL CHEMISTRY; PLANKTON; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS; THREE DIMENSIONAL PRINTING; X RAY POWDER DIFFRACTION; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; KINETICS; MEDICINAL CHEMISTRY; PHARMACEUTICS; POWDER DIFFRACTION; PROCEDURES; SOLUBILITY; SURFACE PROPERTY; X RAY CRYSTALLOGRAPHY;

ANTI-INFECTIVE AGENTS; BIOFILMS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CRYSTALLOGRAPHY, X-RAY; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DURAPATITE; KINETICS; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; NITROFURANTOIN; POLYESTERS; POWDER DIFFRACTION; PRINTING, THREE-DIMENSIONAL; SOLUBILITY; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTIES; TECHNOLOGY, PHARMACEUTICAL;

EID: 84922771762     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.24305     Document Type: Article

References (31)

1. Berman B. 2012. 3-D printing: The new industrial revolution. Bus Horizons 55 (2) : 155-162.
2. Marks P, Campbell M, Aron J, Lipson H. 2011. 3D printing: Second industrial revolution is underway (special report). New Sci 2823: 17-20.
3. Hamburg MA, Collins FS. 2010. The path to personalized medicine. New Engl J Med 363 (4) : 301-304.
4. Lipson H, Kurman M. 2013. Fabricated: The new world of 3D printing. Indianapolis: John Wiley & Sons.
5. Rengier F, Mehndiratta A, von Tengg-Kobligk H, Zechmann CM, Unterhinninghofen R, Kauczor HU, Giesel FL. 2010. 3D printing based on imaging data: Review of medical applications. Int J Comput Assist Radiol Surg 5 (4) : 335-341.
6. Khaled SA, Burley JC, Alexander MR, Roberts CJ. 2014. Desktop 3D printing of controlled release pharmaceutical bilayer tablets. Int J Pharm 461 (1-2) : 105-111.
7. Goyanes A, Buanz AB, Basit AW, Gaisford S. 2014. Fused-filament 3D printing (3DP) for fabrication of tablets. Int J Pharm 476 (1-2) : 88-92.
8. Bose S, Vahabzadeh S, Bandyopadhyay A. 2013. Bone tissue engineering using 3D printing. Mater Today 16 (12) : 496-504.
9. Mannoor MS, Jiang ZW, James T, Kong YL, Malatesta KA, Soboyejo WO, Verma N, Gracias DH, McAlpine MC. 2013. 3D-printed bionic ears. Nano Lett 13 (6) : 2634-2639.
10. Martorelli M, Gerbino S, Giudice M, Ausiello P. 2013. A comparison between customized clear and removable orthodontic appliances manufactured using RP and CNC techniques. Dent Mater 29 (2) : E1-E10.
11. VanNoort R. 2012. The future of dental devices is digital. Dent Mater 28 (1) : 3-12.
12. Sandler N, Salmela I, Fallarero A, Rosling A, Khajeheian M, Kolakovic R, Genina N, Nyman J, Vuorela P. 2014. Towards fabrication of 3D-printed medical devices to prevent biofilm formation. Int J Pharm 459 (1-2) : 62-64.
13. Darouiche RO. 2004. Treatment of infections associated with surgical implants. New Engl J Med 350 (14) : 1422-1429.
14. Leaper D, McBain AJ, Kramer A, Assadian O, Sanchez JLA, Lumio J, Kiernan M. 2010. Healthcare associated infection: Novel strategies and antimicrobial implants to prevent surgical site infection. Ann Roy Coll Surg 92 (6) : 453-458.
15. Franz S, Rammelt S, Scharnweber D, Simon JC. 2011. Immune responses to implants-A review of the implications for the design of immunomodulatory biomaterials. Biomaterials 32 (28) : 6692-6709.
16. Wu P, Grainger DW. 2006. Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials 27 (11) : 2450-2467.
17. Arciola CR, Campoccia D, Speziale P, Montanaro L, Costerton JW. 2012. Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials. Biomaterials 33 (26) : 5967-5982.
18. Goodman SB, Yao ZY, Keeney M, Yang F. 2013. The future of biologic coatings for orthopaedic implants. Biomaterials 34 (13) : 3174-3183.
19. Ghosh SK, Nandi SK, Kundu B, Datta S, De DK, Roy SK, Basu D. 2008. In vivo response of porous hydroxyapatite and beta-Tricalcium phosphate prepared by aqueous solution combustion method and comparison with bioglass scaffolds. J Biomed Mater Res B 86 (1) : 217-227.
20. Nandi SK, Kundu B, Ghosh SK, De DK, Basu D. 2008. Efficacy of nano-hydroxyapatite prepared by an aqueous solution combustion technique in healing bone defects of goat. J Vet Sci 9 (2) : 183-191.
21. Liu J, Gao Y, Cao D, Zhang L, Guo Z. 2011. Nanoparticle dispersion and aggregation in polymer nanocomposites: Insights from molecular dynamics simulation. Langmuir 27 (12) : 7926-7933.
22. Takayama T, Todo M, Takano A. 2009. The effect of bimodal distribution on the mechanical properties of hydroxyapatite particle filled poly (L-lactide) composites. J Mech Behav Biomed 2 (1) : 105-112.
23. Shen DY, Fang LM, Chen XF, Tang YH. 2011. Structure and properties of polyacrylic acid modified hydroxyapatite/liquid crystal polymer composite. J Reinf Plast Comp 30 (13) : 1155-1163.
24. Baumgartner R, Eitzlmayr A, Matsko N, Khinast J, Roblegg E. 2014. Nano-extrusion: A promising tool for continuous manufactering od solid nano-formulations. Int J Pharm 477 (1-2) : 1-11.
25. Caraballo I, Fernandezarevalo M, Holgado MA, Rabasco AM. 1993. Percolation theory-Application to the study of the release behavior from inert matrix systems. Int J Pharm 96 (1-3) : 175-181.
26. Caraballo I, Melgoza LM, Alvarez-Fuentes J, Soriano MC, Rabasco AM. 1999. Design of controlled release inert matrices of naltrexone hydrochloride based on percolation concepts. Int J Pharm 181 (1) : 23-30.
27. Soriano MC, Caraballo I, Millan M, Pinero RT, Melgoza LM, Rabasco AM. 1998. Influence of two different types of excipient on drug percolation threshold. Int J Pharm 174 (1-2) : 63-69.
28. Hou Q, Grijpma DW, Feijen J. 2003. Porous polymeric structures for tissue engineering prepared by a coagulation, compression moulding and salt leaching technique. Biomaterials 24 (11) : 1937-1947.
29. Kramschuster A, Turng L-S. 2010. An injection molding process for manufacturing highly porous and interconnected biodegradable polymer matrices for use as tissue engineering scaffolds. J Biomed Mater Res B 92B (2) : 366-376.
30. Middleton JC, Tipton AJ. 2000. Synthetic biodegradable polymers as orthopedic devices. Biomaterials 21 (23) : 2335-2346.
31. Campoccia D, Montanaro L, Speziale P, Arciola CR. 2010. Antibiotic-loaded biomaterials and the risks for the spread of antibiotic resistance following their prophylactic and therapeutic clinical use. Biomaterials 31 (25) : 6363-6377.